Javascript must be enabled to continue!
The N-terminus of the prion protein is a toxic effector regulated by the C-terminus
View through CrossRef
PrPC, the cellular isoform of the prion protein, serves to transduce the neurotoxic effects of PrPSc, the infectious isoform, but how this occurs is mysterious. Here, using a combination of electrophysiological, cellular, and biophysical techniques, we show that the flexible, N-terminal domain of PrPC functions as a powerful toxicity-transducing effector whose activity is tightly regulated in cis by the globular C-terminal domain. Ligands binding to the N-terminal domain abolish the spontaneous ionic currents associated with neurotoxic mutants of PrP, and the isolated N-terminal domain induces currents when expressed in the absence of the C-terminal domain. Anti-PrP antibodies targeting epitopes in the C-terminal domain induce currents, and cause degeneration of dendrites on murine hippocampal neurons, effects that entirely dependent on the effector function of the N-terminus. NMR experiments demonstrate intramolecular docking between N- and C-terminal domains of PrPC, revealing a novel auto-inhibitory mechanism that regulates the functional activity of PrPC.
eLife Sciences Publications, Ltd
Title: The N-terminus of the prion protein is a toxic effector regulated by the C-terminus
Description:
PrPC, the cellular isoform of the prion protein, serves to transduce the neurotoxic effects of PrPSc, the infectious isoform, but how this occurs is mysterious.
Here, using a combination of electrophysiological, cellular, and biophysical techniques, we show that the flexible, N-terminal domain of PrPC functions as a powerful toxicity-transducing effector whose activity is tightly regulated in cis by the globular C-terminal domain.
Ligands binding to the N-terminal domain abolish the spontaneous ionic currents associated with neurotoxic mutants of PrP, and the isolated N-terminal domain induces currents when expressed in the absence of the C-terminal domain.
Anti-PrP antibodies targeting epitopes in the C-terminal domain induce currents, and cause degeneration of dendrites on murine hippocampal neurons, effects that entirely dependent on the effector function of the N-terminus.
NMR experiments demonstrate intramolecular docking between N- and C-terminal domains of PrPC, revealing a novel auto-inhibitory mechanism that regulates the functional activity of PrPC.
Related Results
Differential Accumulation of Misfolded Prion Strains in Natural Hosts of Prion Diseases
Differential Accumulation of Misfolded Prion Strains in Natural Hosts of Prion Diseases
Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of neurodegenerative protein misfolding diseases that invariably cause death. TSEs occur...
Membrane-anchored PrPSc is the trigger for prion synaptotoxicity
Membrane-anchored PrPSc is the trigger for prion synaptotoxicity
ABSTRACT
The mechanism by which prions composed of PrPSc cause the neuropathological aberrations characteristic of prion diseases remains elusive. Previous studies have...
Seasonality in Terminus Ablation Rates for the Glaciers in Kalaallit Nunaat
(Greenland)
Seasonality in Terminus Ablation Rates for the Glaciers in Kalaallit Nunaat
(Greenland)
Since the 1990s, the Greenland Ice Sheet (GrIS) has undergone accelerated mass
loss, with a substantial portion due to the dynamic effects of terminus retreat.
...
Integrated Organotypic Slice Cultures and RT-QuIC (OSCAR) Assay: Implications for Translational Discovery in Protein Misfolding Diseases
Integrated Organotypic Slice Cultures and RT-QuIC (OSCAR) Assay: Implications for Translational Discovery in Protein Misfolding Diseases
AbstractProtein misfolding is a key pathological event in neurodegenerative diseases like prion diseases, synucleinopathies, and tauopathies that are collectively termed protein mi...
Unaltered prion disease in mice lacking developmental endothelial locus-1 (Del-1)
Unaltered prion disease in mice lacking developmental endothelial locus-1 (Del-1)
Abstract
Progression of prion diseases is driven by the accumulation of prions in the brain. Ablation of microglia or deletion of the eat-me-sign...
Possible Treatments for COVID Vaccine Induced Prion Disease
Possible Treatments for COVID Vaccine Induced Prion Disease
Many COVID-19 “vaccines" are considered bioweapons and are known to have the ability to cause prion disease. Prion inducing agents have been researched extensively as potential bio...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
Capillary electromigration based techniques in diagnostics of prion protein caused diseases
Capillary electromigration based techniques in diagnostics of prion protein caused diseases
Transmissible spongiform encephalopathies are a group of fatal neurodegenerative diseases with long incubation time. This group includes Creutzfeld‐Jakob disease, kuru, scrapie, ch...

